InDex Pharmaceuticals Holding AB (1NP1) Financial Statements
InDex Pharmaceuticals Holding AB Financial Overview
InDex Pharmaceuticals Holding AB's market cap is currently $115.50M. The company's EPS TTM is $-12.02; its P/E ratio is -1.16; InDex Pharmaceuticals Holding AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.80M | $ 100.00K | $ 97.50M | $ 0.00 | $ 0.00 |
| Gross Profit | $ -12.70M | $ -41.60M | $ 93.35M | $ -1.07M | $ -1.25M |
| Operating Income | $ -782.10M | $ -110.80M | $ -107.37M | $ -151.11M | $ -115.63M |
| EBITDA | $ -743.60M | $ -225.70M | $ -93.82M | $ -99.15M | $ -101.66M |
| Net Income | $ -756.90M | $ -228.00M | $ -95.27M | $ -100.33M | $ -103.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 540.20M | $ 865.10M | $ 294.27M | $ 344.93M | $ 428.45M |
| Total Assets | $ 3.40B | $ 4.22B | $ 299.39M | $ 351.34M | $ 445.20M |
| Total Debt | $ 2.10M | $ 800.00K | $ 2.30M | $ 3.25M | $ 1.28M |
| Net Debt | $ -536.50M | $ -864.30M | $ -291.97M | $ -341.68M | $ -427.17M |
| Total Liabilities | $ 20.30M | $ 25.30M | $ 60.50M | $ 17.38M | $ 11.16M |
| Stockholders' Equity | $ 3.38B | $ 4.20B | $ 238.88M | $ 333.96M | $ 434.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -28.10M | $ -17.00M | $ -37.98M | $ -129.44M | $ -124.06M |
| Operating Cash Flow | $ -28.10M | $ -17.00M | $ -37.98M | $ -129.44M | $ -124.06M |
| Investing Cash Flow | $ -109.50M | $ -19.80M | $ -625.20M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -195.50M | $ 571.90M | $ 634.70M | $ -818.00K | $ 486.39M |
Currency in SEK
